New York, NY, United States of America

Petra Pharma Corporation


USPTO Granted Patents = 4

Forward Citations = 1

Loading Chart...
Loading Chart...

28 inventors (with patents filed for the assignee):

goldMedal Edward A Kesicki (4 out of 9 patents)

silverMedal Eugene R Hickey (4 out of 66 patents)

bronzeMedal Gabrielle R Kolakowski (3 out of 58 patents)

4.  Manoj Kumar (3 out of 11 patents)

5.  Christopher Glenn Mayne (3 out of 3 patents)

6.  Nicholas A Boyles (3 out of 3 patents)

7.  Jennifer Lynn Knight (3 out of 3 patents)

8.  Michael Brian Welch (3 out of 3 patents)

9.  Tien Widjaja (3 out of 8 patents)

10.  Katelyn Frances Long (3 out of 3 patents)

11.  Erin Danielle Anderson (3 out of 7 patents)

12.  Thomas Combs Irvin (3 out of 7 patents)

13.  Sean Douglas Aronow (3 out of 17 patents)

14.  Johnathan Alexander McLean (2 out of 9 patents)

15.  Gerit Maria Pototschnig (2 out of 4 patents)


4 patents:

Company Overview
Petra Pharma Corporation is a leading pharmaceutical company dedicated to developing innovative therapies that improve patients' lives. We focus on research and development of novel drugs in various therapeutic areas, including oncology, immunology, and neurology. Our mission is to provide high-quality, safe, and effective medications to meet the unmet medical needs of patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#1,393 in New York, NY

#3,680 in New York

#60,641 in US

New York, NY (US)
New York, NY, United States of America
Forward Citations = 1

28 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Petra Pharma Corporation. Retrieved from https://idiyas.com/company/petra-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…